Evaluating medical oncology outcomes: An Asian lung cancer study

Les Mery; Freddie Ian Bray; Patumrat Sripan; Ross A. Soo; Hans H. Storm; Rolf A. Stahel

doi:10.1093/annonc/mdz432.012

Related publications

Article2007

Evaluating an End-of-Life Curriculum in a Medical Residency Program

Andrew C. Yacht, Shakira Suglia, Jay D. Orlander

Letter2022

The shifting epidemiology of lung cancer in Asian and Asian diaspora populations: Implications for clinical and global health policy research

Edward Christopher Dee, Patricia Mae G. Santos, Freddie Ian Bray

Letter2015

Sentinel node biopsy for melanoma: The medical oncology perspective.

Alexander M. Menzies, Victoria Atkinson, Michael P. Brown, Matteo S. Carlino, Jonathan Cebon, Alexander Guminski, Richard Kefford, Georgina V. Long, Grant A. McArthur, Catriona M. McNeil, Michael Millward, Shahneen Sandhu

Article2014

Docetaxel and intermittent erlotinib in patients with metastatic Non-Small Cell Lung Cancer; a phase II study from the Hellenic Cooperative Oncology Group.

Vasilios Karavasilis, P. Kosmidis, Konstantinos N. Syrigos, Polyxeni Mavropoulou, Meletios A Dimopoulos, Vassiliki Kotoula, Dimitrios Pectasides, Ioannis Boukovinas, G. Klouvas, Anna Kalogera‐Fountzila, Christos N. Papandreou, George Fountzilas, Evangelos Briasoulis

Article2019

Employment Outcomes for Recent Canadian Radiation Oncology Graduates

Shaun Loewen, Ross Halperin, George Perry, Marna B. McKenzie, É. Vigneault, Teri Stuckless, Michael Brundage